Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

376 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.
Klümper N, Tran NK, Zschäbitz S, Hahn O, Büttner T, Roghmann F, Bolenz C, Zengerling F, Schwab C, Nagy D, Toma M, Kristiansen G, Heers H, Ivanyi P, Niegisch G, Grunewald CM, Darr C, Farid A, Schlack K, Abbas M, Aydogdu C, Casuscelli J, Mokry T, Mayr M, Niedersüß-Beke D, Rausch S, Dietrich D, Saal J, Ellinger J, Ritter M, Alajati A, Kuppe C, Meeks J, Vera Badillo FE, Nakauma-González JA, Boormans J, Junker K, Hartmann A, Grünwald V, Hölzel M, Eckstein M. Klümper N, et al. Among authors: meeks j. J Clin Oncol. 2024 Apr 24:JCO2301983. doi: 10.1200/JCO.23.01983. Online ahead of print. J Clin Oncol. 2024. PMID: 38657187
Mechanism of action of nadofaragene firadenovec-vncg.
Narayan VM, Meeks JJ, Jakobsen JS, Shore ND, Sant GR, Konety BR. Narayan VM, et al. Among authors: meeks jj. Front Oncol. 2024 Mar 15;14:1359725. doi: 10.3389/fonc.2024.1359725. eCollection 2024. Front Oncol. 2024. PMID: 38559556 Free PMC article. Review.
The Elusive Horizon: Biomarkers in Urothelial Carcinoma.
Linscott JA, Meeks JJ, Dyrskjøt L, Li R. Linscott JA, et al. Among authors: meeks jj. Eur Urol. 2024 Apr;85(4):317-319. doi: 10.1016/j.eururo.2024.01.004. Epub 2024 Jan 25. Eur Urol. 2024. PMID: 38278663
Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.
Lerner SP, McConkey DJ, Tangen CM, Meeks JJ, Flaig TW, Hua X, Daneshmand S, Alva AS, Lucia MS, Theodorescu D, Goldkorn A, Milowsky MI, Choi W, Bangs R, Gustafson DL, Plets M, Thompson IM Jr. Lerner SP, et al. Among authors: meeks jj. Clin Cancer Res. 2024 Jan 17;30(2):444-449. doi: 10.1158/1078-0432.CCR-23-0602. Clin Cancer Res. 2024. PMID: 37966367 Clinical Trial.
Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial Carcinoma.
Huelster HL, Gould B, Schiftan EA, Camperlengo L, Davaro F, Rose KM, Soupir AC, Jia S, Zheng T, Sexton WJ, Pow-Sang J, Spiess PE, Daniel Grass G, Wang L, Wang X, Vosoughi A, Necchi A, Meeks JJ, Faltas BM, Du P, Li R. Huelster HL, et al. Among authors: meeks jj. Eur Urol. 2024 Mar;85(3):283-292. doi: 10.1016/j.eururo.2023.09.017. Epub 2023 Oct 4. Eur Urol. 2024. PMID: 37802683
Immunotherapy in the Treatment of Localized Genitourinary Cancers.
Necchi A, Faltas BM, Slovin SF, Meeks JJ, Pal SK, Schwartz LH, Huang RSP, Li R, Manley B, Chahoud J, Ross JS, Spiess PE. Necchi A, et al. Among authors: meeks jj. JAMA Oncol. 2023 Oct 1;9(10):1447-1454. doi: 10.1001/jamaoncol.2023.2174. JAMA Oncol. 2023. PMID: 37561425
376 results